Moxalactam. Evaluation of clinical bleeding in patients with abdominal infectionJOEHL, R. J; RASBACH, D. A; BALLARD, J. O et al.Archives of surgery (Chicago, IL. 1960). 1983, Vol 118, Num 11, pp 1259-1261, issn 0004-0010Article

Pulmonary disposition of moxalactamBRAUDE, A. C; COHEN, R. D; PENNER, J. L et al.Chest. 1984, Vol 86, Num 6, pp 881-883, issn 0012-3692Article

ESR identification of radiosterilized pharmaceuticals : latamoxef and ceftriaxoneBASLY, J. P; LONGY, I; BERNARD, M et al.International journal of pharmaceutics. 1997, Vol 158, Num 2, pp 241-245, issn 0378-5173Article

Inhibitory effects of antibiotics on platelet aggregation in vitroKARIYAZONO, H; NAKAMURA, K; SHINKAWA, T et al.Human & experimental toxicology. 1997, Vol 16, Num 11, pp 662-666, issn 0960-3271Article

Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonatesSTUTMAN, H. R; PARKER, M; MARKS, M. I et al.Pediatrics (Evanston). 1985, Vol 75, Num 2, pp 294-298, issn 0031-4005Article

Evolution des taux plasmatiques de décarboxyprothrombine et de vitamine K au cours du traitement par Moxalactam = Plasma levels of decarboxyprothrombin and vitamin K during moxalactam treatmentLEFRERE, J. J; LECLERCQ, M; GUILLAUMONT, M et al.La Revue de médecine interne (Paris). 1988, Vol 9, Num 2, pp 223-225, issn 0248-8663Article

Moxalactam for the treatment of bacterial meningitis in childrenFREEDMAN, J. M; HOFFMAN, S. H; SCHELD, W. M et al.The Journal of infectious diseases. 1983, Vol 148, Num 5, pp 886-891, issn 0022-1899Article

Pourquoi prescrire le latamoxef en 1993 ? Une autre classe de β-lactamines : les oxa-β-lactamines : Florilége de la thérapeutique en hépato-gastro-entérologie. I = Latamoxef treatment: (Moxalactam) the oxa-β-lactam antibioticCHEVREL, B.Médecine et chirurgie digestives (Paris). 1993, Vol 22, Num 1, pp 57-65, issn 0047-6412Article

Trouble de l'hémostase primaire associé à l'administration de lamoxactam = Primary hemostasis abnormality associated with lamoxactamDUVAL, G; SITBON, N; COUTURIER, M et al.Réanimation, soins intensifs, médecine d'urgence. 1985, Vol 1, Num 3, issn 0765-5290, 190Article

Moxalactam therapy of Haemophilus influenzae type b meningitis in childrenCHARTRAND, S. A; MARKS, M. I; SCRIBNER, R. K et al.The Journal of pediatrics. 1984, Vol 104, Num 3, pp 454-459, issn 0022-3476Article

Prospective comparative trial of moxalactam versus ampicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in childrenKAPLAN, S. L; MASON, E. O. JR; MASON, S. K et al.The Journal of pediatrics. 1984, Vol 104, Num 3, pp 447-453, issn 0022-3476Article

Trace determination of shiomarin using a hanging copper/amalgam drop electrodeGU, Hai-Ying.Journal of pharmaceutical and biomedical analysis. 2002, Vol 29, Num 1-2, pp 341-346, issn 0731-7085Article

Moxalactam therapy of serious infectionsVAN DER AUWERA, P; CLUMECK, N; VAN LAETHEM, Y et al.Infection. 1983, Vol 11, Num 4, pp 212-218, issn 0300-8126Article

The effect of control on the pattern of utilization of cefotaxime, moxalactam and cefoperazone in a teaching hospitalMA, M. Y; RHO, J. P.Drugs under experimental and clinical research. 1985, Vol 11, Num 2, pp 89-94, issn 0378-6501Article

Ethanol intolerance with new antibioticsKIEL, D; BARRIERE, S. L.Drug intelligence & clinical pharmacy. 1984, Vol 18, Num 2, pp 134-135, issn 0012-6578Article

Analytical studies on β-lactam antibiotics. II: Displacement effect of β-lactam antibiotics on bilirubin bound to human serum albuminMATSUURA, A; NAGAYAMA, T; KITAGAWA, T et al.Chemotherapy (Basel). 1988, Vol 34, Num 4, pp 345-353, issn 0009-3157Article

Moxalactam epimer disposition in patients undergoing continuous ambulatory peritoneal dialysisMORSE, G; JANICKE, D; CAFARELL, R et al.Clinical pharmacology and therapeutics. 1985, Vol 38, Num 2, pp 150-156, issn 0009-9236Article

Prolonged bleeding time associated with moxalactam administrationFISHMAN, L; MARSH, W. R.Neurosurgery. 1984, Vol 14, Num 6, pp 735-736, issn 0148-396XArticle

Imipenem versus moxalactam in the treatment of serious infectionsERON, L. J; HIXON, D. L; PARK, C. H et al.Antimicrobial agents and chemotherapy. 1983, Vol 24, Num 6, pp 841-846, issn 0066-4804Article

Effect of latamoxef (moxalactam) and its related compounds on platelet aggregation in vitro ― structure activity relationshipsUCHIDA, K; KAKUSHI, H; SHIKE, T et al.Thrombosis research. 1987, Vol 47, Num 2, pp 215-222, issn 0049-3848Article

Defects in vitamin K-dependent carboxylation associated with moxalactam treatmentBARZA, M; FURIE, B; BROWN, A. E et al.The Journal of infectious diseases. 1986, Vol 153, Num 6, pp 1166-1169, issn 0022-1899Article

Pharmacokinetics of moxalactam in elderly subjectsANDRITZ, M. H; SMITH, R. P; BALTH, A. L et al.Antimicrobial agents and chemotherapy. 1984, Vol 25, Num 1, pp 33-36, issn 0066-4804Article

A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancyGIAMARELLOU, H; GAZIS, J; PETRIKKOS, G et al.American journal of obstetrics and gynecology. 1983, Vol 147, Num 8, pp 914-919, issn 0002-9378Article

Effects of latamoxef on in vitro and ex vivo thromboxane A₂ generation in human plateletsMIHARA, S; KAKUSHI, H; SHIKE, T et al.Thrombosis research. 1988, Vol 49, Num 2, pp 215-224, issn 0049-3848Article

Stability and compatibility studies of cefazoline, ceftriaxone, cefotaxime and latamoxef with PVC infusion bagsFAOUZI, M. A; KHALFI, F; CAZIN, J. C et al.Pharmazie. 1996, Vol 51, Num 12, pp 963-966, issn 0031-7144Article